{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T09:20:43Z","timestamp":1789896043592,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T00:00:00Z","timestamp":1521072000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Scientific Research Foundation of Sichuan University for outstanding young scholars","award":["2013SCU04A22"],"award-info":[{"award-number":["2013SCU04A22"]}]},{"name":"The seventh new century education reform projects sponsored by Sichuan University","award":["SCUY7093"],"award-info":[{"award-number":["SCUY7093"]}]},{"name":"Fund of the National Nature Science Foundations","award":["81202387"],"award-info":[{"award-number":["81202387"]}]},{"name":"Sichuan Province Science and Technology Plan Project","award":["2013JY0013\/2014JY0213"],"award-info":[{"award-number":["2013JY0013\/2014JY0213"]}]},{"name":"Demonstration project of Chengdu science and technology","award":["2015-HM02-00075-SF"],"award-info":[{"award-number":["2015-HM02-00075-SF"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12906-018-2127-7","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T09:42:32Z","timestamp":1521106952000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Fisetin and polymeric micelles encapsulating fisetin exhibit potent cytotoxic effects towards ovarian cancer cells"],"prefix":"10.1186","volume":"18","author":[{"given":"Xue","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0406-6018","authenticated-orcid":false,"given":"Peng","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,15]]},"reference":[{"key":"2127_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"2127_CR2","doi-asserted-by":"publisher","first-page":"9741","DOI":"10.3390\/ijms13089741","volume":"13","author":"W Li","year":"2012","unstructured":"Li W, Cai JH, Zhang J, Tang YX, Wan L. Effects of cyclooxygenase inhibitors in combination with taxol on expression of cyclin D1 and Ki-67 in a xenograft model of ovarian carcinoma. Int J Mol Sci. 2012;13:9741\u201353.","journal-title":"Int J Mol Sci"},{"key":"2127_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1158\/1535-7163.MCT-10-0606","volume":"10","author":"R Tripathi","year":"2011","unstructured":"Tripathi R, Samadder T, Gupta S, Surolia A, Shaha C. Anticancer activity of a combination of cisplatin and fisetin in embryonal carcinoma cells and xenograft tumors. Mol Cancer Ther. 2011;10:255\u201368.","journal-title":"Mol Cancer Ther"},{"key":"2127_CR4","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/carcin\/bgn269","volume":"30","author":"Y Suh","year":"2009","unstructured":"Suh Y, Afaq F, Johnson JJ, Mukhtar H. A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt\/EGFR\/NF-kappaB-signaling pathways. Carcinogenesis. 2009;30:300\u20137.","journal-title":"Carcinogenesis"},{"key":"2127_CR5","doi-asserted-by":"publisher","first-page":"5914","DOI":"10.1016\/j.biomaterials.2012.05.012","volume":"33","author":"Z Li","year":"2012","unstructured":"Li Z, Guo X, Guan J. An oxygen release system to augment cardiac progenitor cell survival and differentiation under hypoxic condition. Biomaterials. 2012;33:5914\u201323.","journal-title":"Biomaterials"},{"key":"2127_CR6","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.ijrobp.2010.02.043","volume":"77","author":"WS Chen","year":"2010","unstructured":"Chen WS, Lee YJ, Yu YC, Hsaio CH, Yen JH, Yu SH, Tsai YJ, Chiu SJ. Enhancement of p53-mutant human colorectal cancer cells radiosensitivity by flavonoid fisetin. Int J Radiat Oncol Biol Phys. 2010;77:1527\u201335.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2127_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00204-011-0754-6","volume":"86","author":"TH Ying","year":"2012","unstructured":"Ying TH, Yang SF, Tsai SJ, Hsieh SC, Huang YC, Bau DT, Hsieh YH. Fisetin induces apoptosis in human cervical cancer HeLa cells through ERK1\/2-mediated activation of caspase-8\u2212\/caspase-3-dependent pathway. Arch Toxicol. 2012;86:263\u201373.","journal-title":"Arch Toxicol"},{"key":"2127_CR8","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1167\/iovs.04-1369","volume":"47","author":"A Hanneken","year":"2006","unstructured":"Hanneken A, Lin FF, Johnson J, Maher P. Flavonoids protect human retinal pigment epithelial cells from oxidative-stress-induced death. Invest Ophthalmol Vis Sci. 2006;47:3164\u201377.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2127_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4067\/S0716-97602000000200007","volume":"33","author":"A Crozier","year":"2000","unstructured":"Crozier A, Burns J, Aziz AA, Stewart AJ, Rabiasz HS, Jenkins GI, Edwards CA, Lean ME. Antioxidant flavonols from fruits, vegetables and beverages: measurements and bioavailability. Biol Res. 2000;33:79\u201388.","journal-title":"Biol Res"},{"key":"2127_CR10","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1067\/mai.2003.1456","volume":"111","author":"S Higa","year":"2003","unstructured":"Higa S, Hirano T, Kotani M, Matsumoto M, Fujita A, Suemura M, Kawase I, Tanaka T. Fisetin, a flavonol, inhibits TH2-type cytokine production by activated human basophils. J Allergy Clin Immunol. 2003;111:1299\u2013306.","journal-title":"J Allergy Clin Immunol"},{"key":"2127_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00204-002-0346-6","volume":"76","author":"YC Chen","year":"2002","unstructured":"Chen YC, Shen SC, Lee WR, Lin HY, Ko CH, Shih CM, Yang LL. Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1. Arch Toxicol. 2002;76:351\u20139.","journal-title":"Arch Toxicol"},{"key":"2127_CR12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/sj.pcan.4500845","volume":"9","author":"AQ Haddad","year":"2006","unstructured":"Haddad AQ, Venkateswaran V, Viswanathan L, Teahan SJ, Fleshner NE, Klotz LH. Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines. Prostate Cancer Prostatic Dis. 2006;9:68\u201376.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2127_CR13","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1080\/01635581003605524","volume":"62","author":"AQ Haddad","year":"2010","unstructured":"Haddad AQ, Fleshner N, Nelson C, Saour B, Musquera M, Venkateswaran V, Klotz L. Antiproliferative mechanisms of the flavonoids 2,2\u2032-dihydroxychalcone and fisetin in human prostate cancer cells. Nutr Cancer. 2010;62:668\u201381.","journal-title":"Nutr Cancer"},{"key":"2127_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11010-009-0217-z","volume":"333","author":"CS Chien","year":"2010","unstructured":"Chien CS, Shen KH, Huang JS, Ko SC, Shih YW. Antimetastatic potential of fisetin involves inactivation of the PI3K\/Akt and JNK signaling pathways with downregulation of MMP-2\/9 expressions in prostate cancer PC-3 cells. Mol Cell Biochem. 2010;333:169\u201380.","journal-title":"Mol Cell Biochem"},{"key":"2127_CR15","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1093\/carcin\/bgq115","volume":"31","author":"Y Suh","year":"2010","unstructured":"Suh Y, Afaq F, Khan N, Johnson JJ, Khusro FH, Mukhtar H. Fisetin induces autophagic cell death through suppression of mTOR signaling pathway in prostate cancer cells. Carcinogenesis. 2010;31:1424\u201333.","journal-title":"Carcinogenesis"},{"key":"2127_CR16","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.bcp.2011.07.097","volume":"82","author":"YS Touil","year":"2011","unstructured":"Touil YS, Auzeil N, Boulinguez F, Saighi H, Regazzetti A, Scherman D, Chabot GG. Fisetin disposition and metabolism in mice: identification of geraldol as an active metabolite. Biochem Pharmacol. 2011;82:1731\u20139.","journal-title":"Biochem Pharmacol"},{"key":"2127_CR17","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/j.bcp.2010.02.004","volume":"79","author":"E Ans\u00f3","year":"2010","unstructured":"Ans\u00f3 E, Zuazo A, Irigoyen M, Urdaci MC, Rouzaut A, Mart\u00ednez-Irujo JJ. Flavonoids inhibit hypoxia-induced vascular endothelial growth factor expression by a HIF-1 independent mechanism. Biochem Pharmacol. 2010;79:1600\u20139.","journal-title":"Biochem Pharmacol"},{"key":"2127_CR18","doi-asserted-by":"publisher","first-page":"10496","DOI":"10.1021\/jf202756f","volume":"59","author":"MY Wu","year":"2011","unstructured":"Wu MY, Hung SK, Fu SL. Immunosuppressive effects of fisetin in ovalbumin-induced asthma through inhibition of NF-\u03baB activity. J Agric Food Chem. 2011;59:10496\u2013504.","journal-title":"J Agric Food Chem"},{"key":"2127_CR19","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/j.fct.2010.05.058","volume":"48","author":"JY Kim","year":"2010","unstructured":"Kim JY, Jeon YK, Jeon W, Nam MJ. Fisetin induces apoptosis in Huh-7 cells via downregulation of BIRC8 and Bcl2L2. Food Chem Toxicol. 2010;48:2259\u201364.","journal-title":"Food Chem Toxicol"},{"key":"2127_CR20","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1021\/am5066893","volume":"7","author":"Y Chen","year":"2015","unstructured":"Chen Y, Wu Q, Song L, He T, Li Y, Li L, Su W, Liu L, Qian Z, Gong C. Polymeric micelles encapsulating fisetin improve the therapeutic effect in colon cancer. ACS Appl Mater Interfaces. 2015;7:534\u201342.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2127_CR21","doi-asserted-by":"publisher","unstructured":"Chen G, Gao C, Gao X, Zhang DH, Kuan SF, Burns TF, Hu J. Wnt\/\u03b2-catenin pathway activation mediates adaptive resistance to BRAF inhibition in colorectal cancer. Mol Cancer Ther. 2017. \n                    https:\/\/doi.org\/10.1158\/1535-7163.MCT-17-0561\n                    \n                  .","DOI":"10.1158\/1535-7163.MCT-17-0561"},{"key":"2127_CR22","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/nar\/gkv1515","volume":"18","author":"TG Hopkins","year":"2016","unstructured":"Hopkins TG, Mura M, Al-Ashtal HA, Lahr RM, Abd-Latip N, Sweeney K, Lu H, Weir J, El-Bahrawy M, Steel JH, Ghaem-Maghami S, Aboagye EO. The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer. Nucleic Acids Res. 2016 Feb;18:1227\u201346.","journal-title":"Nucleic Acids Res"},{"key":"2127_CR23","first-page":"156","volume":"25","author":"GMJ Echarri","year":"2011","unstructured":"Echarri GMJ, Green R, Muggia FM. Intraperitoneal drug delivery for ovarian cancer: why, how, who, what, and when. Oncology (Williston Park). 2011;25:156\u201365. 170","journal-title":"Oncology (Williston Park)"},{"key":"2127_CR24","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s12032-012-0424-4","volume":"30","author":"QQ Li","year":"2013","unstructured":"Li QQ, Lee RX, Liang H, Zhong Y, Reed E. Enhancement of cisplatin-induced apoptosis by \u03b2-elemene in resistant human ovarian cancer cells. Med Oncol. 2013;30:424.","journal-title":"Med Oncol"},{"key":"2127_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM199601043340101","volume":"334","author":"WP McGuire","year":"1996","unstructured":"McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, Clarke-Pearson DL, Davidson M. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med. 1996;334:1\u20136.","journal-title":"N Engl J Med"},{"key":"2127_CR26","doi-asserted-by":"publisher","first-page":"8555","DOI":"10.1158\/0008-5472.CAN-08-0240","volume":"68","author":"N Khan","year":"2008","unstructured":"Khan N, Asim M, Afaq F, Abu ZM, Mukhtar H. A novel dietary flavonoid fisetin inhibits androgen receptor signaling and tumor growth in athymic nude mice. Cancer Res. 2008;68:8555\u201363.","journal-title":"Cancer Res"},{"key":"2127_CR27","doi-asserted-by":"publisher","first-page":"516","DOI":"10.4149\/neo_2011_06_516","volume":"58","author":"K Kozics","year":"2011","unstructured":"Kozics K, Valovicova Z, Slamenova D. Structure of flavonoids influences the degree inhibition of benzo(a)pyrene - induced DNA damage and micronuclei in HepG2 cells. Neoplasma. 2011;58:516\u201324.","journal-title":"Neoplasma"},{"key":"2127_CR28","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ejmech.2009.09.041","volume":"45","author":"M Katalini\u0107","year":"2010","unstructured":"Katalini\u0107 M, Rusak G, Doma\u0107inovi\u0107 BJ, Sinko G, Jeli\u0107 D, Antolovi\u0107 R, Kovarik Z. Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase. Eur J Med Chem. 2010;45:186\u201392.","journal-title":"Eur J Med Chem"},{"key":"2127_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mrgentox.2009.12.010","volume":"696","author":"M L\u00f3pez-L\u00e1zaro","year":"2010","unstructured":"L\u00f3pez-L\u00e1zaro M, Willmore E, Austin CA. The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cells. Mutat Res. 2010;696:41\u20137.","journal-title":"Mutat Res"},{"key":"2127_CR30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1742-7843.2010.00613.x","volume":"108","author":"J Li","year":"2011","unstructured":"Li J, Cheng Y, Qu W, Sun Y, Wang Z, Wang H, Tian B. Fisetin, a dietary flavonoid, induces cell cycle arrest and apoptosis through activation of p53 and inhibition of NF-kappa B pathways in bladder cancer cells. Basic Clin Pharmacol Toxicol. 2011;108:84\u201393.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2127_CR31","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1002\/ijc.26178","volume":"130","author":"N Khan","year":"2012","unstructured":"Khan N, Afaq F, Khusro FH, Mustafa AV, Suh Y, Mukhtar H. Dual inhibition of phosphatidylinositol 3-kinase\/Akt and mammalian target of rapamycin signaling in human nonsmall cell lung cancer cells by a dietary flavonoid fisetin. Int J Cancer. 2012;130:1695\u2013705.","journal-title":"Int J Cancer"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-018-2127-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-018-2127-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-018-2127-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T20:14:08Z","timestamp":1552594448000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-018-2127-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,15]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2127"],"URL":"https:\/\/doi.org\/10.1186\/s12906-018-2127-7","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,15]]},"assertion":[{"value":"21 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients gave written informed consent for the study, which was approved by the local research ethics committee (The ethics committee of Sichuan University). The current animal study was approved by the Regional Administrative Authority in Sichuan University, P.R. China. All the cells were bought from ATCC(American type culture collection), the partial are primary cells.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"91"}}